RT Journal Article
SR Electronic
T1 Hyperchloraemic metabolic acidosis
JF Emergency Medicine Journal
JO Emerg Med J
FD BMJ Publishing Group Ltd and the British Association for Accident & Emergency Medicine
SP 613
OP 613
DO 10.1136/emj.2008.059923
VO 25
IS 9
A1 F S Y Fan
A1 K M Chow
A1 C C Szeto
A1 P K T Li
YR 2008
UL http://emj.bmj.com/content/25/9/613.abstract
AB Cholestyramine carries a risk of hyperchloraemic metabolic acidosis. Being cognisant of this drug-induced adverse event may reduce diagnostic delays. Emergency physicians should be alert about this condition, in particular among patients with pre-existing chronic kidney disease, or who are taking spironolactone.